Pos FJ - Search Results

1

Patterns of Recurrence and Survival After Pelvic Treatment for Locally Advanced Penile Cancer.

de Vries HM, Ottenhof SR, Rafael TS, van Werkhoven E, Pos FJ, van Rhijn BWG, Moonen LMF, Graafland N, de Feijter JM, Schaake EE, Horenblas S, Brouwer OR. de Vries HM, et al. Among authors: pos fj. Eur Urol Open Sci. 2022 Dec 15;47:29-35. doi: 10.1016/j.euros.2022.11.005. eCollection 2023 Jan. Eur Urol Open Sci. 2022. PMID: 36601037 Free PMC article.

2

Correction to Lancet Oncol 2015; 16: 274.

Aluwini S, Pos F, Schimmel E. Aluwini S, et al. Lancet Oncol. 2015 Mar;16(3):e105. doi: 10.1016/S1470-2045(15)70096-3. Lancet Oncol. 2015. PMID: 25752558 No abstract available.

3

Behavior of lipiodol markers during image guided radiotherapy of bladder cancer.

Chai X, van Herk M, van de Kamer JB, Remeijer P, Bex A, Betgen A, De Reijke TM, Hulshof MC, Pos FJ, Bel A. Chai X, et al. Among authors: pos fj. Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):309-14. doi: 10.1016/j.ijrobp.2009.08.019. Epub 2010 Feb 4. Int J Radiat Oncol Biol Phys. 2010. PMID: 20137863

4

[Good results of bladder-preserving treatment in poorly differentiated and invasive bladder carcinoma using interstitial Iridium-192 radiotherapy].

Moonen LM, Horenblas S, Pos F, Schaefer BS, Meinhardt W, Bartelink H. Moonen LM, et al. Ned Tijdschr Geneeskd. 1996 Jul 6;140(27):1406-10. Ned Tijdschr Geneeskd. 1996. PMID: 8766684 Dutch.

5

Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.

Pos FJ, Horenblas S, Lebesque J, Moonen L, Schneider C, Sminia P, Bartelink H. Pos FJ, et al. Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):696-705. doi: 10.1016/j.ijrobp.2003.11.040. Int J Radiat Oncol Biol Phys. 2004. PMID: 15183473

6

Brachytherapy in the treatment of invasive bladder cancer.

Pos F, Moonen L. Pos F, et al. Semin Radiat Oncol. 2005 Jan;15(1):49-54. doi: 10.1016/j.semradonc.2004.07.012. Semin Radiat Oncol. 2005. PMID: 15662607 Review. No abstract available.

7

Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer.

Bex A, Nieuwenhuijzen JA, Kerst M, Pos F, van Boven H, Meinhardt W, Horenblas S. Bex A, et al. Urology. 2005 Feb;65(2):295-9. doi: 10.1016/j.urology.2004.09.049. Urology. 2005. PMID: 15708041

8

Organ preservation in invasive bladder cancer: brachytherapy, an alternative to cystectomy and combined modality treatment?

Pos F, Horenblas S, Dom P, Moonen L, Bartelink H. Pos F, et al. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):678-86. doi: 10.1016/j.ijrobp.2004.06.249. Int J Radiat Oncol Biol Phys. 2005. PMID: 15708245

9

Survival after bladder-preservation with brachytherapy versus radical cystectomy; a single institution experience.

Nieuwenhuijzen JA, Pos F, Moonen LM, Hart AA, Horenblas S. Nieuwenhuijzen JA, et al. Eur Urol. 2005 Aug;48(2):239-45. doi: 10.1016/j.eururo.2005.03.022. Epub 2005 Apr 13. Eur Urol. 2005. PMID: 16005375

10

Adaptive radiotherapy for invasive bladder cancer: a feasibility study.

Pos FJ, Hulshof M, Lebesque J, Lotz H, van Tienhoven G, Moonen L, Remeijer P. Pos FJ, et al. Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):862-8. doi: 10.1016/j.ijrobp.2005.07.976. Int J Radiat Oncol Biol Phys. 2006. PMID: 16458776

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

120 results

Search Page